The ADC targets FOLR1 on tumor cells, is internalized, and releases a hemiasterlin payload that binds beta-tubulin to inhibit microtubule polymerization, causing mitotic arrest and cell death; killing is driven by FOLR1 targeting, not by beta-tubulin expression itself.